[{"data":1,"prerenderedAt":131},["ShallowReactive",2],{"trials":3},[4,44,73,101],{"id":5,"title":6,"address":7,"body":8,"city":25,"contact":7,"country":26,"description":14,"extension":27,"medicine":28,"meta":29,"name":30,"navigation":31,"path":32,"phone":7,"region":33,"registry":7,"seo":34,"sponsor":35,"status":36,"stem":37,"substances":38,"summary":40,"verified":41,"website":42,"__hash__":43},"trials\u002Ftrials\u002Fcentre-for-neurology-studies-surrey.md","Centre For Neurology Studies Surrey",null,{"type":9,"value":10,"toc":21},"minimark",[11,15,18],[12,13,14],"p",{},"Trials are the only way to receive psilocybin for alcohol use disorder legally in Canada outside a Special Access Program request, and they are free. They also have strict entry criteria and a chance of receiving a low dose. Status changes; check the registry link before contacting a site.",[12,16,17],{},"This is the only BC site we have found registering people for a psilocybin trial in alcohol use disorder. The Centre for Neurology Studies is a private research site that runs industry-sponsored trials; its registration page lists a psilocybin-assisted psychotherapy study for adults 18 to 70 who want to reduce or stop alcohol use.",[12,19,20],{},"We have not confirmed the sponsor, registry entry or current recruitment status, which is why this listing is marked as not yet checked. Ask for the ClinicalTrials.gov identifier when you enquire.",{"title":22,"searchDepth":23,"depth":23,"links":24},"",2,[],"Surrey","CA","md","psilocybin",{},"Centre for Neurology Studies — psilocybin-assisted psychotherapy for alcohol use disorder",true,"\u002Ftrials\u002Fcentre-for-neurology-studies-surrey","BC",{"description":14},"Centre for Neurology Studies (private research site)","Listed as registering participants; confirm current status","trials\u002Fcentre-for-neurology-studies-surrey",[39],"alcohol","A private clinical research site in Surrey, BC, registering adults aged 18 to 70 who want to reduce or stop drinking for a psilocybin-assisted psychotherapy study.","null","https:\u002F\u002Fcentreforneurologystudies.com\u002Fregister-for-a-study\u002F","L9xxr1Y5O0pIgK9Dwqzc9PW1BZZ9xjf5gZuoojK4pfo",{"id":45,"title":46,"address":7,"body":47,"city":59,"contact":7,"country":26,"description":14,"extension":27,"medicine":28,"meta":60,"name":61,"navigation":31,"path":62,"phone":7,"region":63,"registry":7,"seo":64,"sponsor":65,"status":66,"stem":67,"substances":68,"summary":69,"verified":70,"website":71,"__hash__":72},"trials\u002Ftrials\u002Fqueens-khsc-clairvoyant-aud.md","Queens Khsc Clairvoyant Aud",{"type":9,"value":48,"toc":57},[49,51,54],[12,50,14],{},[12,52,53],{},"Queen's University and Kingston Health Sciences Centre are a site for Clairvoyant Therapeutics' Phase 2b trial, which tests a single 25 mg dose of psilocybin against a 1 mg comparison dose, both with motivational enhancement therapy, in people who have been drinking heavily and want to cut down. Participants with much prior hallucinogen experience are excluded.",[12,55,56],{},"Contact the site through the Queen's announcement page; the trial may have additional Canadian sites.",{"title":22,"searchDepth":23,"depth":23,"links":58},[],"Kingston",{},"Queen's University \u002F KHSC — psilocybin therapy for alcohol use disorder","\u002Ftrials\u002Fqueens-khsc-clairvoyant-aud","ON",{"description":14},"Clairvoyant Therapeutics (Vancouver)","Announced; check current recruitment","trials\u002Fqueens-khsc-clairvoyant-aud",[39],"A Phase 2b trial at Kingston Health Sciences Centre combining psilocybin with motivational enhancement therapy, sponsored by a Vancouver biotech aiming to bring psilocybin therapy for alcohol use disorder to Canada, the UK and the EU.","2026-09-19","https:\u002F\u002Fhealthsci.queensu.ca\u002Fstories\u002Fnews-announcements\u002Fqueens-and-khsc-launch-clinical-trial-psilocybin-therapy-treat-alcohol","CVTZZpX8lbQDjubpDsSmhs0N8stUYXuozHQXT4AgmZE",{"id":74,"title":75,"address":7,"body":76,"city":88,"contact":7,"country":26,"description":14,"extension":27,"medicine":28,"meta":89,"name":90,"navigation":31,"path":91,"phone":7,"region":92,"registry":7,"seo":93,"sponsor":94,"status":95,"stem":96,"substances":97,"summary":98,"verified":70,"website":99,"__hash__":100},"trials\u002Ftrials\u002Fucalgary-psilocybin-aud.md","Ucalgary Psilocybin Aud",{"type":9,"value":77,"toc":86},[78,80,83],[12,79,14],{},[12,81,82],{},"Run out of the Cumming School of Medicine's PaCT Lab, this randomised trial pairs a single psilocybin session, at a high or low dose, with motivational enhancement therapy. Each participant is assigned one therapist for the whole trial, receives up to eight hours of preparation before dosing and five weekly sessions after. The stated aim is to find out not just whether it works but for whom and why.",[12,84,85],{},"The lab's site carries the recruitment form. Participants need to be in Calgary for the study visits.",{"title":22,"searchDepth":23,"depth":23,"links":87},[],"Calgary",{},"University of Calgary — psilocybin-assisted psychotherapy for alcohol use disorder","\u002Ftrials\u002Fucalgary-psilocybin-aud","AB",{"description":14},"University of Calgary (PaCT Lab, Dr Leah Mayo)","Recruiting as of mid-2026","trials\u002Fucalgary-psilocybin-aud",[39],"Canada's largest single-site psilocybin trial for alcohol use disorder: 128 participants, high or low dose, up to eight hours of preparation and five weekly therapy sessions afterward.","https:\u002F\u002Fwww.pactlab.ca","R3JTxH1lST4u7h8JSnYo0UAuccpwBuCOJkxcnUKMRxY",{"id":102,"title":103,"address":7,"body":104,"city":116,"contact":7,"country":117,"description":14,"extension":27,"medicine":28,"meta":118,"name":119,"navigation":31,"path":120,"phone":7,"region":121,"registry":122,"seo":123,"sponsor":124,"status":125,"stem":126,"substances":127,"summary":128,"verified":70,"website":129,"__hash__":130},"trials\u002Ftrials\u002Fuw-psilostudy-seattle.md","Uw Psilostudy Seattle",{"type":9,"value":105,"toc":114},[106,108,111],[12,107,14],{},[12,109,110],{},"PsiloStudy came out of a 2023 Washington law that ordered a state study of psilocybin. It enrols a small cohort of veterans and first responders with both alcohol use disorder and PTSD, treated with psilocybin and psychological support, with follow-up for up to six months and compensation of up to $550. Led by an addiction psychiatrist at UW.",[12,112,113],{},"Eligibility is narrow by design. The pre-screen survey is linked from the institute's page.",{"title":22,"searchDepth":23,"depth":23,"links":115},[],"Seattle","US",{},"University of Washington — PsiloStudy (alcohol use disorder with PTSD)","\u002Ftrials\u002Fuw-psilostudy-seattle","WA","NCT06853912",{"description":14},"University of Washington Addictions, Drug & Alcohol Institute; funded under Washington SB 5263","Recruiting as of early 2025; confirm before applying","trials\u002Fuw-psilostudy-seattle",[39],"A state-mandated Washington study of psilocybin with psychological support for veterans and first responders who have both alcohol use disorder and PTSD.","https:\u002F\u002Fadai.uw.edu\u002F?p=12844","Oq5ip8Hq2RzbRjjufXTQ_e4f43uimwTvhinj2aqngxE",1791062337062]